Enhancing Bioactivity of Nanofibrous Poly(Caprolactone)/45S5 Bioglass Composite Scaffolds by Incorporation of Ag, GO, and ZnO Nanoparticles

Abstract

The present study endeavors toward the investigation on the bioactivity of nanofibrous scaffolds manufactured by the electrospinning process. Nanofibrous composite scaffolds of PCL with 45S5 bioactive glass and metal oxide nanoparticles were developed and characterized. The effects of incorporating silver (Ag), graphene oxide (GO), and zinc oxide (ZnO) nanoparticles into PCL/bioglass nanofibrous scaffolds on its geometry and physiochemical, morphological, mechanical, and biological properties were studied. The incorporation of GO and ZnO alters the fiber diameter, suggesting the methodology for controlling the porosity of the scaffolds. The results of FTIR and XRD confirm the structure of bioglass, Ag, GO and ZnO nanoparticles. The in vitro degradation studies in SBF solution provide evidence for the enhancement in the rate of apatite formation by the inclusion of nanoparticles as compared with PCL/BG scaffolds. The assessment of mechanical properties suggests the tensile strength was increased from 1.61 to 5 MPa in PCL/BG/ZnO system when compared with pristine PCL. The cell viability is also observed to be improved from 72% to 91% and 104% for PCL/BG/GO and PCL/BG/ZnO, respectively. The hemolytic activity studies confirm that all scaffolds are nonhemolytic in nature and PCL/BG/ZnO exhibits the least hemolytic activity of 0.65% among the other composite scaffolds, suggesting the better blood compatibility. The present study evidently shows the fact that incorporation of GO and ZnO nanoparticles with PCL in addition to BG accelerates the bioactivity and improves the mechanical strength of the scaffold.